Avrobio Inc. (AVRO) PT Lowered to $14 at Wedbush, Following Clinical Business Update
Tweet Send to a Friend
Wedbush analyst David Nierengarten lowered the price target on Avrobio Inc. (NASDAQ: AVRO) to $14.00 (from $30.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
